2nd Quarter - Report

HEARTFLOW, INC. for HEARTFLOW, INC.

Period 2nd Quarter 2026 Filed Jul 21, 2026 Signed by Rachel Kosh

Official filing
Firm
HEARTFLOW, INC.
Client
HEARTFLOW, INC.
Income
—
Expenses
$100,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to physician payments; issues related to Medicare reimbursement; issues related to Medicare reimbursement of AI-enabled technology; Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717/H.R. 5343); Health Tech Investment Act (S. 1399/H.R. 6197); H.R. 9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027, issues related to health care, generally.

LobbyistCovered position, as disclosed
RACHEL ANN KOSH —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 9260 (119th), S. 1399 (119th), S. 1717 (119th), H.R. 6197 (119th), H.R. 5343 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.